Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1

[Northerner]

BOSTON, MA, USA I May 20, 2013 I Rhythm announced today the results of a second Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis in type 1 diabetic patients. The trial demonstrated that RM-131 significantly accelerates early gastric emptying and reduces upper gastrointestinal (GI) symptoms in type 1 diabetic patients with diabetic gastroparesis. The findings were presented at the Digestive Disease Week 2013 conference in Orlando and recently published in Clinical Gastroenterology and Hepatology.

http://www.pipelinereview.com/index...paresis-in-Patients-with-Type-1-Diabetes.html